Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS) IPO
IPO
Priced at US$15.00 a share on Mar 22, 2016.
- Price
- US$15.00 a share
- Shares offered
- 4,700,000 shares of common stock
- Offering size
- US$70.5 million
- Underwriters' option
- Up to 705,000 more shares
- Listing
- CRVS on the Nasdaq Global Market
- Underwriters
- Credit Suisse, Cowen and Company, Guggenheim Securities, Cantor Fitzgerald & Co., BTIG · In the order on the cover
- Shares delivered
- On or about Mar 29, 2016
Steps
| Step | When |
|---|---|
| Draft sent to the SEC in confidence | Nov 6, 2015 |
| Filed publicly | Jan 4, 2016 |
| Amended twice | Newest Mar 10, 2016 |
| Shares registered with an exchange | Mar 16, 2016 |
| Declared effective by the SEC | Mar 22, 2016 |
| Final prospectus, with the price | Mar 24, 2016 |
Filings
| Filing | Filed |
|---|---|
| 424B4 · Prospectus | Mar 24, 2016 |
| EFFECT · Notice that a registration is effective | Mar 22, 2016 |
| CERTNAS · Nasdaq's certificate of listing | Mar 21, 2016 |
| CORRESP · Letter to the SEC | Mar 18, 2016 |
| CORRESP · Letter to the SEC | Mar 18, 2016 |
| 8-A12B · Registration of shares for listing on an exchange | Mar 16, 2016 |
| S-1/A · Registration statement, amended | Mar 10, 2016 |
| CORRESP · Letter to the SEC | Feb 8, 2016 |
| S-1/A · Registration statement, amended | Feb 8, 2016 |
| CORRESP · Letter to the SEC | Jan 4, 2016 |
| S-1 · Registration statement | Jan 4, 2016 |
| DRSLTR · Letter to the SEC with a draft | Dec 10, 2015 |
| DRS/A · Draft registration statement, amended | Dec 10, 2015 |
| UPLOAD · Letter from the SEC | Dec 7, 2015 |
| DRS · Draft registration statement | Nov 6, 2015 |
From the cover of the final prospectus (424B4) filed Mar 24, 2016